Details for New Drug Application (NDA): 206827
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 206827
Tradename: | CELECOXIB |
Applicant: | Aurobindo Pharma |
Ingredient: | celecoxib |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206827
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 206827
Suppliers and Packaging for NDA: 206827
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 206827 | ANDA | Aurobindo Pharma Limited | 65862-907 | 65862-907-60 | 60 CAPSULE in 1 BOTTLE (65862-907-60) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 206827 | ANDA | Aurobindo Pharma Limited | 65862-907 | 65862-907-99 | 1000 CAPSULE in 1 BOTTLE (65862-907-99) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Feb 1, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 1, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 1, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription